Skip to main content

The human genome may be the next big API to hit the market

dna nanomachines dna1
Kentoh/Shutterstock
Manipulating the human genome, at least on a large scale, still exists primarily in the realm of science fiction. But soon, scientists may develop an API for our genetic code, making interactions with our DNA faster, easier, and more robust.

In recent months, there has been a concerted impetus from the tech community to partner with researchers and scientists, combining software and hardware innovations with the more specialized know-how of medical professionals. There was the announcement in May regarding Apple’s partnership with American researchers to “help launch apps that would offer some iPhone owners the chance to get their DNA tested,” and the more recent activation of the Google Genomics Lab and Broad Institute partnership to combine the processing power of the Google cloud with the expertise of Harvard and MIT researchers.

Recommended Videos

All these developments, BaseHealth CEO Prakash Menon says, is part of what he calls the “third wave” of genomics, “focused on integrating genomic data with other types of data.” The first wave came about with the early 1990s debut of the Human Genome Project, soon followed by the second wave, categorized by the leveraging of “fast, cheap genome-sequencing technology for disease treatment and therapy.”

But now, Menon believes, we are in the process of discovering “a wide variety of health and well-being apps and platforms will be able to do things like connect variants to environmental, lifestyle, dietary, and activity related factors, guiding both sick and healthy people towards a fundamentally better quality of life.”

And as exciting as all this is, it’s the next wave, the fourth wave, that Menon is particularly excited about. The continued exploration and subsequent understanding of human biology, coupled with advances in technology will almost inevitably lead to a genomic API. As Menon says, “If genome sequencing is fast and cheap, analysis and interpretation are accurate, and genomic data is put into a wider context so that we can leverage insights in daily practice, many new things quickly become possible.” A few of the potential applications he notes in a guest post for VentureBeat include:

  • Pharmacy support systems that integrate with your genome to ensure that prescription drugs are ideal for the subject, maximizing efficacy and reducing side effects
  • Organ and/or bone marrow donor matching application that uses the genome to make the process of matching more streamlined and efficient
  • An athletic training application that uses genetic information to adjust routines, rest periods, supplements, and diet

“I can even imagine,” Menon writes, “a world in which online role playing/MMO games use a genomic API to build worlds around each player that reference his or her molecular reality.” The possibilities are endless, and we’re just now starting to realize our full potential — welcome to the future.

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Ford ships new NACS adapters to EV customers
Ford EVs at a Tesla Supercharger station.

Thanks to a Tesla-provided adapter, owners of Ford electric vehicles were among the first non-Tesla drivers to get access to the SuperCharger network in the U.S.

Yet, amid slowing supply from Tesla, Ford is now turning to Lectron, an EV accessories supplier, to provide these North American Charging Standard (NACS) adapters, according to InsideEVs.

Read more
Yamaha offers sales of 60% on e-bikes as it pulls out of U.S. market
Yamaha Pedal Assist ebikes

If you were looking for clues that the post-pandemic e-bike market reshuffle remains in full swing in the U.S., look no further than the latest move by Yamaha.

In a letter to its dealers, the giant Japanese conglomerate announced it will pull out of the e-bike business in the U.S. by the end of the year, according to Electrek.

Read more
Rivian offers $3,000 off select EVs to gasoline, hybrid vehicle drivers
Second-Gen Rivian R1S on a road

Early November typically kicks off the run-up to the Black Friday sales season, and this year, Rivian is betting it’s the perfect time to lure gasoline drivers toward its EVs.
If you own or lease a vehicle that runs on gasoline, which means even a hybrid vehicle, Rivian is ready to give you $3,000 off the purchase of one of its select fully electric vehicles -- no trade-in required.
The offer from the Irvine, California-based automaker extends to customers in the U.S. and Canada and runs through November 30, 2024. The program applies to Rivian 2025 R1S or R1T Dual Large, Dual Max, or Tri Max models purchased from R1 Shop.
Rivian’s new All-Electric Upgrade offer marks a change from a previous trade-in program that ran between April and June. There, owners of select 2018 gas-powered vehicles from Ford, Toyota, Jeep, Audi, and BMW could trade in their vehicle and receive up to $5,000 toward the purchase of a new Rivian.
This time, buyers of the R1S or R1T Rivian just need to provide proof of ownership or lease of a gas-powered or hybrid vehicle to receive the discount when they place their order.
Rivian is not going to be the only car maker offering discounts in November. Sluggish car sales from giants such as Stellantis and rising inventories of new cars due to improving supply chains suggest automakers and dealerships will be competing to offer big incentives through the year's end.
This follows several years of constrained supply following the COVID pandemic, which led to higher prices in North America.
According to CarEdge Insights, average selling prices for cars remain above what would be called affordable. But prices should continue improving along with rising inventories.
Stellantis brands are entering November with the most inventory, followed by GM and Ford, according to CarEdge. Toyota and Honda, meanwhile, have the least inventory, meaning they probably won’t be under pressure to offer big incentives.

Read more